Ever since SEBI disallowed abstinence for mutual funds, voting in favour of resolutions has come down from 93% to 88% Read More | Source: The Hindu Business Line…
View More Will Gen Z of stock markets wake up and vote in corporate resolutions?Tag: Stock Market
Meesho IPO opens Dec 3; company eyes AI investment, user growth post-listing
The offer comprises a fresh issue of ₹4,250 crore and an offer for sale of up to 10.55 crore shares by existing shareholders Read More | Source: The Hindu Business Line…
View More Meesho IPO opens Dec 3; company eyes AI investment, user growth post-listingMarkets end flat after record high as rate cut hopes support sentiment
Sectoral performance was uneven, with Nifty Auto advancing 0.6 per cent to hit a fresh record high and Nifty Pharma gaining 0.6 per cent, supported by resilient retail demand and improving trends across segments Read More | Source: The Hindu Business Line…
View More Markets end flat after record high as rate cut hopes support sentimentBroker’s call: Belrise Ind (Buy)
JM Financial Read More | Source: The Hindu Business Line…
View More Broker’s call: Belrise Ind (Buy)Sensex, Nifty 50 flat ahead of Q2 GDP data; Adani stocks, M&M lead gainers of Nifty 50
Traders on a wait-and-watch approach ahead of today’s Q2 GDP print Read More | Source: The Hindu Business Line…
View More Sensex, Nifty 50 flat ahead of Q2 GDP data; Adani stocks, M&M lead gainers of Nifty 50GAIL shares fall 6.5% after PNGRB announces 12% tariff hike
The tariff order raises the integrated pipeline rate from ₹58.60 per MMBtu to ₹65.69, and will come into effect from January 1, 2026 Read More | Source: The Hindu Business Line…
View More GAIL shares fall 6.5% after PNGRB announces 12% tariff hikeOneSource building on capacity to tap into Ozempic ingredient – semaglutide – opportunity
Not dependent on single customer or event, say top brass, as couple of customers involved with semaglutide patent challenges Read More | Source: The Hindu Business Line…
View More OneSource building on capacity to tap into Ozempic ingredient – semaglutide – opportunityLenskart shares flat after 5% surge as Jefferies initiates coverage with buy rating
Momentum builds as markets await Lenskart’s Q2 results tomorrow. Read More | Source: The Hindu Business Line…
View More Lenskart shares flat after 5% surge as Jefferies initiates coverage with buy ratingSudeep Pharma shares end 30% above ₹593-IPO price after stellar listing
The stock began trading at ₹733.95 on the BSE, a 23.7% premium to the IPO price of ₹593. On the NSE, it opened at ₹730, reflecting a 23% premium, setting a strong tone for its first day of trade Read More | Source: The Hindu Business Line…
View More Sudeep Pharma shares end 30% above ₹593-IPO price after stellar listingMarkets hit consolidation phase after record highs, Nifty eyes 26,300 resistance
Among Nifty50 constituents, Mahindra & Mahindra led the gainers, surging 1.69% to ₹3,743.30, followed by Adani Enterprises at ₹2,271.60, up 0.74% Read More | Source: The Hindu Business Line…
View More Markets hit consolidation phase after record highs, Nifty eyes 26,300 resistanceCapital Group buys CarTrade Tech shares worth ₹440 cr
The shares were picked up at an average price of ₹3,044.58 apiece, taking the transaction value of ₹439.91 crore Read More | Source: The Hindu Business Line…
View More Capital Group buys CarTrade Tech shares worth ₹440 crSudeep Pharma Share Price Highlights: Shares soar after premium listing
Sudeep Pharma IPO listing today, Sudeep Pharma share price live updates: Read More | Source: The Hindu Business Line…
View More Sudeep Pharma Share Price Highlights: Shares soar after premium listingFrom Adani Enterprises, LG Electronics India, Ashoka Buildcon, RVNL, TVS Motor, TMB, to Lodha Developers, here are a dozen stocks to watch
Key triggers: NHAI suspension, order wins, strategic acquisition, maintenance shutdown, refund Read More | Source: The Hindu Business Line…
View More From Adani Enterprises, LG Electronics India, Ashoka Buildcon, RVNL, TVS Motor, TMB, to Lodha Developers, here are a dozen stocks to watchThree pharma stocks to remain in focus in Friday’s trade (November 28, 2025)
Key positive and negative triggers for Zydus Life, Emcure Pharmaceuticals and Bajaj Healthcare Read More | Source: The Hindu Business Line…
View More Three pharma stocks to remain in focus in Friday’s trade (November 28, 2025)Why these 3 IT stocks will be in focus
Buzzing stocks: Tata Technologies, TCS, Wipro Read More | Source: The Hindu Business Line…
View More Why these 3 IT stocks will be in focus